Research And Development In Biotechnology in Maryland 6th District (MD-06)
$1,662,613,055.98 in USAspending.gov obligations pairs NAICS 541711 (Research And Development In Biotechnology) with Maryland 6th District (MD-06) across 41 awards. The join is NAICS 541711 crossed with an MD-06 location field, not Maryland's entire biotechnology book and not a named-laboratory inventory. The dollars are commitments, not Treasury outlays. No fiscal year is published in this packet, so this page does not invent one.
Key figures
- Research And Development In Biotechnology (NAICS 541711) × MD-06: $1,662,613,055.98 across 41 awards.
- About 6.0% of the MD-06 district parent $27,489,268,187.93 by arithmetic.
- 41 awards are a row count, not a laboratory or vendor census.
- Obligations are not outlays; no fiscal year is in the packet.
- FEC donations do not fund this USAspending cell; source is USAspending.gov.
NAICS 541711 × MD-06 is a biotechnology R&D join, not a lab roster
This page is a join: Research And Development In Biotechnology (NAICS 541711) as the industry key, and Maryland 6th District (MD-06) as congressional district place of performance. SpendingVault sums tagged obligations to $1,662,613,055.98 on 41 awards. The join is NAICS 541711 crossed with an MD-06 location field, not Maryland's entire biotechnology book and not a named-laboratory inventory. Treat the pair as a catalog intersection, not a ranking of which district received more, and not a claim that 41 awards equal 41 laboratories or 41 unique primes.
The MD-04 and MD-05 541715 except-nano/bio R&D joins sit outside this total unless they also carry NAICS 541711 and MD-06. Mixing those books into $1,662,613,055.98 would invent a combined figure the packet never computed. Correlation between this obligation sum and local biotechnology employment is not causation. Laboratory names and investigator counts are not in the packet. Place of performance as MD-06 locates the tagged awards; it does not deposit $1,662,613,055.98 in a district treasury. Frederick-versus-Hagerstown folklore is not a geography split in this packet.
41 awards behind $1.66 billion
Mean obligation is about $40,551,537.95 if $1,662,613,055.98 were divided evenly across 41 lines. That ratio is not a published grant size and not a typical biotech invoice. Award count is a row count, including possible continuations and modifications. It is not a count of labs, trials, or unique vendors. Forty-one awards against a $1.66 billion cell is a moderately concentrated biotechnology file, thinner than MD-05's one-hundred-eighty-nine-award 541715 join.
Research modifications can add rows without adding unique laboratories. This page will not invent contractor or recipient names. Open Maryland 6th District for the stored district table. Do not convert 41 into a map of Maryland 6th District biotech labs. The $1,662,613,055.98 total remains an obligation rollup on tagged awards. Inspect named lines on the overlay rather than inferring a laboratory census.
Maryland 6th District, not a statewide biotech rollup
Maryland 6th District (MD-06) is one geography tag on USAspending awards, not a commuting zone and not a metro list. Awards tagged to MD-04, MD-05, or another Maryland district are out even if the biotech program sounds related. Recipient address can differ from that district tag. The district parent in this extract is $27,489,268,187.93 across every industry; $1,662,613,055.98 is the Research And Development In Biotechnology slice — about 6.0% of that parent by arithmetic. Subtracting is tempting; this page still does not publish the leftover NAICS list.
A statewide biotechnology R&D figure on Maryland federal spending is a different shelf. Do not rank MD-06 against neighboring districts as a winner or loser. Other Maryland district cells are other joins. Maryland federal spending is the statewide book without a district filter. Adding statewide Research And Development In Biotechnology dollars to $1,662,613,055.98 would double count. Campaign-finance filings are a different public-record system; this join does not claim donations funded these obligations.
NAICS 541711 obligations are not trials already closed
Biotechnology R&D awards often obligate as multi-year research vehicles and draw as work proceeds. The $1,662,613,055.98 headline is the obligation sum, not a punch-list of trials already closed and not a Treasury outlay total. A biotechnology R&D dashboard dated to a particular year is not automatically this join unless it uses NAICS 541711, MD-06 geography, and the obligation metric.
NAICS 541711 is the nationwide industry book without a MD-06 filter. This extract does not split agricultural from medical biotechnology, and it does not merge except-biotech R&D (541712 or 541715) into this 541711 code. Those cuts would require award documentation beyond dollars, 41 awards, NAICS 541711, and Maryland 6th District. This page will not invent a share. Unique recipients remain unpublished.
What the MD-06 biotechnology R&D table omits
The extract has no laboratory names, primes, or investigator counts. Facts remain $1,662,613,055.98, 41 awards, NAICS 541711, Research And Development In Biotechnology, Maryland 6th District (MD-06), and district parent $27,489,268,187.93. Western Maryland biotech folklore belongs on another extract if it appears at all. Keep the obligation label. Later ingests can revise both the dollars and the 41-award count; prefer the live table when the overlay and this snapshot diverge.
Where the 541711 × MD-06 pair lives
Start with Maryland 6th District for the district rollup that contains this Research And Development In Biotechnology cell. NAICS 541711 is the nationwide NAICS 541711 listing. Maryland federal spending gives Maryland context without a MD-06 filter. All spending ties indexes other two-key joins on the same obligation metric. Forty-one awards totaling this cell remain an administrative file, not a laboratory roster. Keep both Research And Development In Biotechnology and Maryland 6th District (MD-06) in every citation sentence. Do not recast $1,662,613,055.98 as cash already paid or as Maryland's entire biotechnology appropriation. USAspending.gov remains the source; SpendingVault republishes the join. FEC contribution tables do not fund this cell.
Questions
- How much biotechnology R&D is obligated in Maryland 6th District?
- USAspending.gov shows $1,662,613,055.98 in Research And Development In Biotechnology (NAICS 541711) obligations with Maryland 6th District (MD-06) as place of performance, across 41 awards. The sum is a commitment total, not outlays and not the district's full $27,489,268,187.93 parent. Other NAICS codes sit outside this join unless they also carry 541711.
- Do 41 awards mean 41 biotech labs in MD-06?
- No. Award count is a row count of NAICS 541711 actions tagged to MD-06. It is not a lab or vendor census. Unique recipients are unpublished. Mean obligation of about $40,551,537.95 is a quotient of $1,662,613,055.98 and 41.
- Does the MD-06 cell include MD-05 except-nano/bio R&D?
- No. NAICS 541715 in MD-05 is a different industry and district join. $1,662,613,055.98 is about 6.0% of the Maryland 6th District parent $27,489,268,187.93 by arithmetic. Cite USAspending.gov as the source.
- Is the MD-06 biotechnology R&D total already paid as outlays?
- Not on this metric. Obligations are recorded commitments on awards. Outlays are payments from the Treasury. The $1,662,613,055.98 headline is the obligation rollup in SpendingVault's extract. Invoice draws and remaining balances are not published here. Cite USAspending.gov as the source.
USAspending.gov congressional district place-of-performance joined to NAICS industry. Obligations are not outlays.